Literature DB >> 6323989

Fibronectin receptors on Trypanosoma cruzi trypomastigotes and their biological function.

M A Ouaissi, D Afchain, A Capron, J A Grimaud.   

Abstract

Successful invasion of mammalian cells by pathogenic parasites is generally considered, from circumstantial evidence, to be a consequence of specific mechanisms of recognition of cell surface components--this has stimulated investigations of the biochemical characterization of such molecules. Several studied of trypanosomiasis have examined the ability of parasites to interact with mammalian cells. However, knowledge of the mammalian cell surface 'receptors' which interact with the parasite is limited. We now report that fibronectin, which is a high molecular weight glycoprotein present in blood, connective tissue and at cell surfaces, binds specifically to Trypanosoma cruzi trypomastigotes. The reaction is specific, reversible (in the presence of a 100-fold molar excess of unlabelled ligand) and of moderate affinity (Kd = 11.36 nM). Various other proteins (for example, thyroglobulin, ferritin, catalase, aldolase, human IgG and bovine serum albumin) had no significant effect on the binding of labelled ligand to the parasite surface. Addition of anti-fibronectin antibodies to the culture medium significantly inhibited the infection of rat fibroblasts (3T3 FR) by T. cruzi trypomastigotes, suggesting that cell surface fibronectin may act as a recognition site for attachment of the parasites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323989     DOI: 10.1038/308380a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  28 in total

1.  A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV.

Authors:  J M Santana; P Grellier; J Schrével; A R Teixeira
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes.

Authors:  M T Rimoldi; A J Tenner; D A Bobak; K A Joiner
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

3.  Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection.

Authors:  Swinburne A J Augustine; Yuliya Y Kleshchenko; Pius N Nde; Siddharth Pratap; Edward A Ager; James M Burns; Maria F Lima; Fernando Villalta
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells.

Authors:  S T Pottratz; W J Martin
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

5.  Activation of complement receptor 3 on human monocytes by cross-linking of very-late antigen-5 is mediated via protein tyrosine kinases.

Authors:  B M van den Berg; R van Furth; W L Hazenbos
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

Review 6.  Comparative biology of intracellular parasitism.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1985-09

7.  Trypanosoma cruzi but not Trypanosoma brucei fails to induce a chemiluminescent signal in a macrophage hybridoma cell line.

Authors:  B Vray; P De Baetselier; A Ouaissi; Y Carlier
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Matrix metalloproteinase-2, -9 and -13 are involved in fibronectin degradation of rat lung granulomatous fibrosis caused by Angiostrongylus cantonensis.

Authors:  Cheng-Chin Hsu; Shih-Chan Lai
Journal:  Int J Exp Pathol       Date:  2007-12       Impact factor: 1.925

9.  Identification of a beta 1 integrin on Mycobacterium avium-Mycobacterium intracellulare.

Authors:  S P Rao; K R Gehlsen; A Catanzaro
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

10.  In vitro parasite-monocyte interactions in human leishmaniasis: possible role of fibronectin in parasite attachment.

Authors:  D J Wyler; J P Sypek; J A McDonald
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.